具有角结构的短化水凝,用于疏水性抗瘤药物输送和受控释放
Qingqing Yao1, Jie Gao1, Linsheng Liu1
1Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
Colloids and surfaces. B, Biointerfaces
|May 17, 2025
概括
一种新型的10氨基酸水凝有效地为癌症治疗提供了帕克利塔塞尔 (PTX). 这种pH敏感的水凝在酸性瘤微环境中释放PTX,增强疗效并减少副作用.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 癌症治疗方法 癌症治疗方法
背景情况:
- 像帕克利塔塞尔 (PTX) 这样的疏水性抗瘤药物在临床使用中面临挑战,原因是溶解性和生物可用性差.
- 由于其生物相容性和可调节性质,基提供了一个有前途的药物递送系统.
- 开发具有成本效益的响应性基凝对于有效的疏水性药物输送至关重要.
研究的目的:
- 设计和合成一个短,pH值敏感的酸水凝,用于水性抗瘤药物的向输送.
- 为了研究水凝在响应瘤微环境时封装和释放帕克利塔塞尔 (PTX) 的能力.
- 评估作为药物输送系统的基凝的体外和体内疗效和安全性.
主要方法:
- 一个具有独特角结构的10氨基酸 (KK) 的固相合成.
- 在不同的pH下,水凝形成,微观结构 (TEM) 和二次结构变化 (循环二元化) 的表征.
- 实验室药物释放研究,注射性风湿学实验,细胞毒性测定和体内抗瘤疗效研究.
- 在体外和体内生物相容性评估.
主要成果:
- 短KK在中性pH下形成了一个稳定的水凝网络,适合包利塔塞尔 (PTX) 纳入.
- 水凝在轻微酸性条件下显示持续的PTX释放,模仿瘤微环境.
- 风病学研究证实了水凝的注射性.
- 试验室和体内研究表明,药物加载的水凝具有增强的抗瘤作用和良好的生物相容性,并减少了有毒副作用.
结论:
- 一种pH敏感的10氨基酸水凝 (KK) 有效地封装并输送帕克利塔塞尔 (PTX).
- 水凝在酸性瘤环境中表现出持续的药物释放,提高了治疗疗效和安全性.
- 这种短基凝代表了一种具有成本效益和临床效益的方法,用于疏水性抗癌药物输送.
更多相关视频
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
108
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
108
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
146
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
146
01:24Modified-Release Drug Delivery Systems: Site-Targeted
144
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
144
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
132
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
132